Workflow
Suli Co., Ltd.(603585)
icon
Search documents
苏利股份(603585) - 苏利股份关于持股5%以上股东及其一致行动人权益变动触及1%刻度的提示性公告
2025-12-18 09:32
| 证券代码:603585 | 证券简称:苏利股份 | 公告编号:2025-086 | | --- | --- | --- | | 转债代码:113640 | 转债简称:苏利转债 | | 江苏苏利精细化工股份有限公司 关于持股 5%以上股东及其一致行动人权益变动触及 1%刻度的提 示性公告 相关股东保证向本公司提供的信息真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息 一致。 一、信息披露义务人及其一致行动人的基本信息 1.身份类别 投资者及其一致行动人的身份 ☑控股股东/实际控制人及其一致行动人 □其他 5%以上大股东及其一致行动人 □合并口径第一大股东及其一致行动人(仅适用 于无控股股东、实际控制人) □其他______________(请注明) 3.一致行动人信息 | 一致行动人名称 | 投资者身份 | 统一社会信用代码 | | --- | --- | --- | | 缪金凤 | ☑ 控股股东/实控人 □ 控股股东/实控人的一致 | □ _____________ 不适用 ☑ | | | 行动人 | | | | □ 其他直接持股股东 ...
苏利股份:沽盛投资已减持0.43%股份
Ge Long Hui· 2025-12-18 09:20
格隆汇12月18日丨苏利股份(603585.SH)公布,公司于2025年12月18日收到沽盛投资的通知,获知其于 2025年12月1日至2025年12月17日,通过集中竞价交易方式减持公司股票798,160股,占公司总股本的 0.43%。本次权益变动后,沽盛投资持有公司股份数量从1,800万股减少至1,720.1840万股,其持股比例 由9.63%降至9.20%。沽盛投资及其一致行动人合计持有公司股份数量从12,600万股减少至12,520.1840万 股,沽盛投资及其一致行动人的持股比例由67.42%降至66.99%,权益变动触及1%刻度。 ...
苏利股份(603585.SH):沽盛投资已减持0.43%股份
Ge Long Hui A P P· 2025-12-18 09:19
格隆汇12月18日丨苏利股份(603585.SH)公布,公司于2025年12月18日收到沽盛投资的通知,获知其于 2025年12月1日至2025年12月17日,通过集中竞价交易方式减持公司股票798,160股,占公司总股本的 0.43%。本次权益变动后,沽盛投资持有公司股份数量从1,800万股减少至1,720.1840万股,其持股比例 由9.63%降至9.20%。沽盛投资及其一致行动人合计持有公司股份数量从12,600万股减少至12,520.1840万 股,沽盛投资及其一致行动人的持股比例由67.42%降至66.99%,权益变动触及1%刻度。 ...
农化制品板块12月18日涨0.03%,苏利股份领涨,主力资金净流出4.29亿元
证券之星消息,12月18日农化制品板块较上一交易日上涨0.03%,苏利股份领涨。当日上证指数报收于 3876.37,上涨0.16%。深证成指报收于13053.98,下跌1.29%。农化制品板块个股涨跌见下表: 从资金流向上来看,当日农化制品板块主力资金净流出4.29亿元,游资资金净流入1.25亿元,散户资金 净流入3.03亿元。农化制品板块个股资金流向见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 ...
151只股中线走稳 站上半年线
Market Overview - The Shanghai Composite Index closed at 3876.74 points, above the six-month moving average, with a change of 0.17% [1] - The total trading volume of A-shares reached 1,352.099 billion yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 151 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Xingchen Technology (21.97%) - Lude Medical (14.72%) - Suli Co., Ltd. (7.17%) [1] Stocks with Smaller Deviation Rates - Stocks with smaller deviation rates that have just crossed the six-month moving average include: - Huailong Co., Ltd. - Shihong Zhaoye - China Construction Bank [1] Detailed Stock Performance - The following stocks showed notable performance: - Xingchen Technology: +30.00% with a turnover rate of 37.59% and a latest price of 26.48 yuan [1] - Lude Medical: +18.92% with a turnover rate of 37.56% and a latest price of 12.07 yuan [1] - Suli Co., Ltd.: +9.99% with a turnover rate of 7.67% and a latest price of 20.36 yuan [1]
170只股中线走稳 站上半年线
Market Overview - The Shanghai Composite Index is at 3877.49 points, above the six-month moving average, with a change of 0.19% [1] - The total trading volume of A-shares today is 1,059.316 billion yuan [1] Stocks Performance - A total of 170 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Xingchen Technology (20.65%) - Lude Medical (8.88%) - Suli Co., Ltd. (7.17%) [1] - Stocks with smaller deviation rates that have just crossed the six-month line include Donghua Testing, Jinling Pharmaceutical, and Delisi [1] Top Stocks by Deviation Rate - The top three stocks with the highest deviation rates are: 1. Xingchen Technology: 28.57% increase, trading at 26.19 yuan, with a deviation rate of 20.65% [1] 2. Lude Medical: 12.81% increase, trading at 11.45 yuan, with a deviation rate of 8.88% [1] 3. Suli Co., Ltd.: 9.99% increase, trading at 20.36 yuan, with a deviation rate of 7.17% [1] Additional Stocks with Notable Performance - Other stocks with significant performance include: - Beimo High-tech: 10.01% increase, trading at 30.65 yuan, deviation rate of 5.86% [1] - Shaoyang Hydraulic: 11.75% increase, trading at 30.82 yuan, deviation rate of 5.83% [1] - Zhejiang Zhongcheng: 10.04% increase, trading at 5.37 yuan, deviation rate of 5.23% [1]
苏利股份:公司部分原药产品会用于制剂产品生产
Zheng Quan Ri Bao· 2025-12-12 12:37
Group 1 - The company, Sully Co., stated that some of its raw material products will be used in the production of formulated products, such as Bacillus thuringiensis and Pyraclostrobin [2]
苏利股份:溴系列阻燃目前销售正常
Zheng Quan Ri Bao Wang· 2025-12-12 12:11
证券日报网讯12月12日,苏利股份(603585)在互动平台回答投资者提问时表示,公司溴系列阻燃目前 销售正常,产能利用率较好。 ...
苏利股份:苏利制药板块目前主要从事医药中间体研发及生产
Zheng Quan Ri Bao Wang· 2025-12-12 12:11
Group 1 - The core viewpoint of the article is that Suli Co., Ltd. (603585) is currently facing losses in its pharmaceutical intermediate segment due to various factors such as market competition and the overall economic environment [1] - The company plans to enhance its management level, reduce costs internally, and expand its market externally to improve its performance and create greater value for shareholders [1]
苏利股份:公司将通过不断提升管理水平等方式提升公司效益
Zheng Quan Ri Bao· 2025-12-12 11:06
证券日报网讯 12月12日,苏利股份在互动平台回答投资者提问时表示,公司将通过不断提升管理水 平、内部降本增效、外部拓展市场等方式提升公司效益,为股东创造更大的价值。 (文章来源:证券日报) ...